Editorial: Balancing tumor necrosis factor receptor i and tumor necrosis factor receptor ii jointly for joint inflammation

Arthritis and Rheumatology

Volumn 66, Issue 10, 2014, Pages 2657-2660

  Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CASPASE; ETANERCEPT; INFLIXIMAB; PHOSPHOTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; ANTIINFLAMMATORY AGENT;

ARTHRITIS; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DEATH; ENZYME ACTIVATION; HUMAN; NONHUMAN; PROTEIN BINDING; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; INFLAMMATION; JOINT; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANTI-INFLAMMATORY AGENTS; HUMANS; INFLAMMATION; JOINTS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION;

EID: 84908389493     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38753     Document Type: Review

References (15)

1. Aggarwal BB, Kohr WJ, Hass PE, Moffat M, Spencer SA, Henzel WJ, et al. Human tumor necrosis factor: production, purification and characterization. J Biol Chem 1985; 260: 2345-54.
2. Pennica D, Nedwin GE, Hayflick JF, Seeburg PH, Palladino MA, Kohr WJ, et al. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724-9.
3. Aggarwal BB,. Signaling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3: 745-6.
4. Aggarwal BB, Gupta SC, Kim JH,. Historical perspectives on tumor necrosis factor and its superfamily: twenty-five years later, a golden journey. Blood 2012; 119: 651-5.
5. Haridas V, Darnay BG, Natarajan K, Heller R, Aggarwal BB,. Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, NF-κB activation and c-Jun kinase activation. J Immunol 1998; 160: 3152-62.
6. Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR, et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 1998; 160: 943-52.
7. Bluml S, Scheinecker C, Smolen JS, Redlich K,. Targeting TNF receptors in rheumatoid arthritis. Int Immunol 2012; 24: 275-81.
8. Aggarwal BB, Eessalu TE, Hass PE,. Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 1985; 318: 665-7.
9. Manna SK, Aggarwal BB,. Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-κB, AP-1, and c-Jun N-terminal kinase: comparison with interleukin-13. J Biol Chem 1998; 273: 33333-41.
10. Grinberg-Bleyer Y, Saadoun D, Baeyens A, Billiard F, Goldstein JD, Gregoire S, et al. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J Clin Invest 2010; 120: 4558-68.
11. McCann FE, Perocheau DP, Ruspi G, Blazek K, Davies ML, Feldmann M, et al. Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis. Arthritis Rheumatol 2014; 66; 2728-38.
12. Chen X, Baumel M, Mannel DN, Howard OM, Oppenheim JJ,. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol 2007; 179: 154-61.
13. Tada Y, Ho A, Koarada S, Morito F, Ushiyama O, Suzuki N, et al. Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1. Clin Immunol 2001; 99: 325-33.
14. Bluml S, Binder NB, Niederreiter B, Polzer K, Hayer S, Tauber S, et al. Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis. Arthritis Rheum 2010; 62: 1608-19.
15. Higuchi Y, McTiernan CF, Frye CB, McGowan BS, Chan TO, Feldman AM,. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-α-induced cardiomyopathy. Circulation 2004; 109: 1892-7.